COVID-19 with different severities: A multicenter study of clinical features

American Journal of Respiratory and Critical Care Medicine

Volumn 201, Issue 11, 2020, Pages 1380-1388

  Feng, Yun ^a   Ling, Yun ^b   Bai, Tao ^c   Xie, Yusang ^a   Huang, Jie ^a   Li, Jian ^a   Xiong, Weining ^a   Yang, Dexiang ^d   Chen, Rong ^a   Lu, Fangying ^a   Lu, Yunfei ^b   Liu, Xuhui ^b   Chen, Yuqing ^a   Li, Xin ^e   Li, Yong ^a   Summah, Hanssa Dwarka ^f   Lin, Huihuang ^a   Yan, Jiayang ^a   Zhou, Min ^a   Lu, Hongzhou ^b   Qu, Jieming ^a   more..

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI PUBLIC HEALTH CLINICAL CENTER   (China)

^c Wuhan Jinyintan Hospital   (China)

^d Tongling People's Hospital   (China)

^e FUDAN UNIVERSITY   (China)

^f Rivière du Rempart   (Mauritius)

Author keywords

ACEI ARB; COVID 19; Multiple lung lobe involvement; Pleural effusion; Severity

Indexed keywords

ALANINE AMINOTRANSFERASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIFUNGAL AGENT; ANTIHYPERTENSIVE AGENT; ARBIDOL; ASPARTATE AMINOTRANSFERASE; AZITHROMYCIN; BILIRUBIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCIUM; CD3 ANTIGEN; CD4 ANTIGEN; CEFTRIAXONE; CHLOROQUINE; CORTICOSTEROID; D DIMER; DARUNAVIR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; LOPINAVIR; MOXIFLOXACIN; MYOGLOBIN; PROCALCITONIN; SERUM ALBUMIN; STAVUDINE; TROPONIN; ALBUMIN; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BILIRUBIN GLUCURONIDE; CREATINE KINASE; CREATINE KINASE MB; CREATININE; FIBRINOGEN; HEMOGLOBIN; LACTIC ACID; POTASSIUM; SODIUM; UREA;

ADULT; AGED; ARTICLE; CHINA; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; COUGHING; CRITICAL ILLNESS; DIARRHEA; DISEASE SEVERITY; DYSPNEA; FEMALE; FEVER; GASTROINTESTINAL DISEASE; GROUPS BY AGE; HEMOPTYSIS; HUMAN; IMAGE ANALYSIS; IMMUNOPATHOLOGY; INCIDENCE; LABORATORY TEST; LUNG LOBE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; MYALGIA; NEUROLOGIC DISEASE; PANDEMIC; PLEURA EFFUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SORE THROAT; SURVIVAL RATE; THORAX PAIN; TREATMENT INDICATION; AGE; BETACORONAVIRUS; CLINICAL TRIAL; CORONAVIRUS INFECTION; EPIDEMIOLOGY; HOSPITAL MORTALITY; LUNG; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; VIROLOGY; VIRUS PNEUMONIA; X-RAY COMPUTED TOMOGRAPHY; ANTIBIOTIC THERAPY; ANTIFUNGAL THERAPY; ANTIHYPERTENSIVE THERAPY; ANTIVIRAL THERAPY; CORTICOSTEROID THERAPY; ERYTHROCYTE SEDIMENTATION RATE; ESTIMATED GLOMERULAR FILTRATION RATE; EXTRACORPOREAL OXYGENATION; HIGH FLOW NASAL CANNULA THERAPY; INVASIVE VENTILATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; NASAL CANNULA THERAPY; NEUTROPHIL COUNT; PLATELET COUNT; SHIVERING; SPUTUM;

ADULT; AGE FACTORS; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BETACORONAVIRUS; CHINA; COMORBIDITY; CORONAVIRUS INFECTIONS; CRITICAL ILLNESS; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; LUNG; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PANDEMICS; PLEURAL EFFUSION; PNEUMONIA, VIRAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85083865576     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.202002-0445OC     Document Type: Article

References (28)

1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565–574.
2. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270–273.
3. World Health Organization. Coronavirus disease (COVID-19). Situation report - 112 [accessed 2020 May 12]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200511-covid-19-sitrep-112.pdf?sfvrsn=813f2669_2.
4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395: 507–513.
5. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020;323:1061–1069.
6. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA [online ahead of print] 24 Feb 2020; DOI: 10.1001/jama.2020.2648.
7. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al.; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med [online ahead of print] 28 Feb 2020; DOI: 10.1056/nejmoa2002032.
8. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506.
9. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020;94: e00127-20.
10. Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 2020; 63:457–460.
11. Li W, Sui J, Huang IC, Kuhn JH, Radoshitzky SR, Marasco WA, et al. The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology 2007;367:367–374.
12. Wu K, Li W, Peng G, Li F. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proc Natl Acad Sci USA 2009;106:19970–19974.
13. He L, Ding Y, Zhang Q, Che X, He Y, Shen H, et al. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE21 cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol 2006;210:288–297.
14. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020;367:1260–1263.
15. Zhao Y, Zhao ZX, Wang YJ, Zhou YQ, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov [preprint]. bioRxiv; 2020 [accessed 2020 Feb 21]. Available from: https://www.biorxiv.org/content/10.1101/2020.01.26. 919985v1.
16. Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005;111:2605–2610.
17. Veit S, Jany S, Fux R, Sutter G, Volz A. CD81 T cells responding to the Middle East respiratory syndrome coronavirus nucleocapsid protein delivered by vaccinia virus MVA in mice. Viruses 2018;10:718.
18. Channappanavar R, Fett C, Zhao J, Meyerholz DK, Perlman S. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. J Virol 2014;88:11034–11044.
19. Wong RS, Wu A, To KF, Lee N, Lam CW, Wong CK, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003;326: 1358–1362.
20. Cui W, Fan Y, Wu W, Zhang F, Wang JY, Ni AP. Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome. Clin Infect Dis 2003;37:857–859.
21. Li T, Qiu Z, Zhang L, Han Y, He W, Liu Z, et al. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. J Infect Dis 2004;189:648–651.
22. Wan SX, Yi QJ, Fan SB, Lv JL, Zhang XX, Guo L, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP) [preprint]. medRxiv; 2020 [accessed 2020 Feb 21]. Available from: https://www.medrxiv.org/content/10.1101/2020.02.10.20021832v1.
23. Qureshi NR, Hien TT, Farrar J, Gleeson FV. The radiologic manifestations of H5N1 avian influenza. J Thorac Imaging 2006;21: 259–264.
24. Pereira JM, Moreno RP, Matos R, Rhodes A, Martin-Loeches I, Cecconi M, et al.; ESICM H1N1 Registry Steering Committee; ESICM H1N1 Registry Contributors. Severity assessment tools in ICU patients with 2009 influenza A (H1N1) pneumonia. Clin Microbiol Infect 2012;18: 1040–1048.
25. Shi SJ, Li H, Liu M, Liu YM, Zhou F, Liu B, et al. Mortality prediction to hospitalized patients with influenza pneumonia: PO2/FiO2 combined lymphocyte count is the answer. Clin Respir J 2017;11:352–360.
26. Guo L, Wei D, Zhang X, Wu Y, Li Q, Zhou M, et al. Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score. Front Microbiol 2019;10:2752.
27. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med [online ahead of print] 13 Mar 2020; DOI: 10.1001/jamainternmed.2020.0994.
28. Niederman MS, Richeldi L, Chotirmall SH, Bai C. Rising to the challenge of the novel SARS-coronavirus-2 (SARS-CoV-2): advice for pulmonary and critical care and an agenda for research. Am J Respir Crit Care Med [online ahead of print] 23 Mar 2020; DOI: 10.1164/rccm.202003-0741ED.